[Autoimmune polyendocrine syndrome type 1].
Proust-Lemoine
E
E
Laboratoire d'Immunologie, EA2686, CHU de Lille, France.
Saugier-Veber
P
P
Lefebvre
H
H
Lefranc
D
D
Prin
L
L
Weill
J
J
Carel
J-C
JC
Wemeau
J-L
JL
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010281:Parathyroid Hormone / Q000627:therapeutic use; D016884:Polyendocrinopathies, Autoimmune / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D011379:Prognosis
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D010281:Parathyroid Hormone